RIGEL PHARMACEUTICALS INC Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Rigel Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • Rigel Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was -14.8 %, a 115% decline year-over-year.
  • Rigel Pharmaceuticals Inc annual Return On Equity for 2023 was 88.9 %, a 88.5% decline from 2022.
  • Rigel Pharmaceuticals Inc annual Return On Equity for 2022 was 773 %.
  • Rigel Pharmaceuticals Inc annual Return On Equity for 2021 was -31.6 %, a 39.7% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -14.8 -115 -115% Jul 1, 2024 Sep 30, 2024
Q2 2024 46.6 -129 -73.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 65.9 -225 -77.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 88.9 -684 -88.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 99.9 +2.52K Jul 1, 2023 Sep 30, 2023
Q2 2023 176 +583 Apr 1, 2023 Jun 30, 2023
Q1 2023 291 +510 Jan 1, 2023 Mar 31, 2023
Q4 2022 773 +804 Oct 1, 2022 Dec 31, 2022
Q3 2022 -2.42K Jul 1, 2022 Sep 30, 2022
Q2 2022 -407 Apr 1, 2022 Jun 30, 2022
Q1 2022 -219 Jan 1, 2022 Mar 31, 2022
Q4 2021 -31.6 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.